Clinical trial
A Non-interventional Patient Study to Demonstrate Medical Utility of the lncRNA to Predict HF in AMI Patients
NCT03322436 is registered in ClinicalTrials.gov with Firalis SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Patient Study to Demonstrate Medical Utility of the lncRNA to Predict HF in AMI Patients
- Lead sponsor
- Firalis SA
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 13, 2018
- Completion date
- October 31, 2022
- Enrollment
- 240 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ami patients